Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).
Otsuka T, Mori M, Yano Y, Uchida J, Nishino K, Kaji R, Hata A, Hattori Y, Urata Y, Kaneda T, Tachihara M, Imamura F, Katakami N, Negoro S, Morita S, Yokota S. Otsuka T, et al. Among authors: yokota s. Anticancer Res. 2015 Jul;35(7):3885-91. Anticancer Res. 2015. PMID: 26124334
Nuclear survivin expression in small cell lung cancer.
Yano Y, Otsuka T, Hirano H, Uenami T, Satomi A, Kuroyama M, Niinaka M, Yoneda T, Kimura H, Mori M, Yamaguchi T, Yokota S. Yano Y, et al. Among authors: yokota s. Anticancer Res. 2015 May;35(5):2935-9. Anticancer Res. 2015. PMID: 25964579
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
Hata A, Katakami N, Hattori Y, Tanaka K, Fujita S, Kotani Y, Nishimura T, Imamura F, Yokota S, Satouchi M, Monden K, Otsuka K, Nishiyama A, Tsubouchi K, Kaneda T, Yoshioka H, Morita S, Negoro S. Hata A, et al. Among authors: yokota s. Cancer Chemother Pharmacol. 2017 Apr;79(4):689-695. doi: 10.1007/s00280-017-3259-z. Epub 2017 Mar 9. Cancer Chemother Pharmacol. 2017. PMID: 28280972 Clinical Trial.
Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.
Takimoto T, Kijima T, Otani Y, Nonen S, Namba Y, Mori M, Yokota S, Minami S, Komuta K, Uchida J, Imamura F, Furukawa M, Tsuruta N, Fujio Y, Azuma J, Tachibana I, Kumanogoh A. Takimoto T, et al. Among authors: yokota s. Clin Lung Cancer. 2013 Sep;14(5):502-7. doi: 10.1016/j.cllc.2013.03.003. Epub 2013 May 9. Clin Lung Cancer. 2013. PMID: 23664723
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y, Hataji O, Takeda Y, Aoe K, Kim YH, Yokota S, Tabeta H, Tomii K, Ohashi Y, Eguchi K, Watanabe K. Takayama K, et al. Among authors: yokota s. Support Care Cancer. 2016 Aug;24(8):3473-80. doi: 10.1007/s00520-016-3156-8. Epub 2016 Mar 22. Support Care Cancer. 2016. PMID: 27003901 Free PMC article.
Case series of pleomorphic carcinomas of the lung treated with nivolumab.
Kanazu M, Uenami T, Yano Y, Nakatsubo S, Hosono Y, Ishijima M, Akazawa Y, Yamaguchi T, Urasaki K, Mori M, Yokota S. Kanazu M, et al. Among authors: yokota s. Thorac Cancer. 2017 Nov;8(6):724-728. doi: 10.1111/1759-7714.12505. Epub 2017 Sep 7. Thorac Cancer. 2017. PMID: 28881488 Free PMC article.
1,731 results